176 related articles for article (PubMed ID: 38711461)
1. Cannabidiol alleviates carbon tetrachloride-induced liver fibrosis in mice by regulating NF-κB and PPAR-α pathways.
Ma R; Xie N; Shu Y; Wu Y; He P; Xiang Y; Zhou Y; Wang Y
Exp Biol Med (Maywood); 2024; 249():10141. PubMed ID: 38711461
[TBL] [Abstract][Full Text] [Related]
2. Salvianolic acid A suppresses CCl
Li S; Wang R; Song F; Chen P; Gu Y; Chen C; Yuan Y
Drug Chem Toxicol; 2023 Mar; 46(2):304-313. PubMed ID: 35057680
[TBL] [Abstract][Full Text] [Related]
3. Hepatoprotective effect of total flavonoids of Mallotus apelta (Lour.) Muell.Arg. leaf against carbon tetrachloride-induced liver fibrosis in rats via modulation of TGF-β1/Smad and NF-κB signaling pathways.
Zhang B; Lai L; Tan Y; Liang Q; Bai F; Mai W; Huang Q; Ye Y
J Ethnopharmacol; 2020 May; 254():112714. PubMed ID: 32105750
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of MAPK and NF-κB signaling pathways alleviate carbon tetrachloride (CCl4)-induced liver fibrosis in Toll-like receptor 5 (TLR5) deficiency mice.
Shu M; Huang DD; Hung ZA; Hu XR; Zhang S
Biochem Biophys Res Commun; 2016 Feb; 471(1):233-9. PubMed ID: 26845355
[TBL] [Abstract][Full Text] [Related]
5. Antifibrotic effects of Fraxetin on carbon tetrachloride-induced liver fibrosis by targeting NF-κB/IκBα, MAPKs and Bcl-2/Bax pathways.
Wu B; Wang R; Li S; Wang Y; Song F; Gu Y; Yuan Y
Pharmacol Rep; 2019 Jun; 71(3):409-416. PubMed ID: 31003150
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effects of quercetin on the progression of liver fibrosis through the regulation of NF-кB/IкBα, p38 MAPK, and Bcl-2/Bax signaling.
Wang R; Zhang H; Wang Y; Song F; Yuan Y
Int Immunopharmacol; 2017 Jun; 47():126-133. PubMed ID: 28391159
[TBL] [Abstract][Full Text] [Related]
7. The involvement of Nrf2 in the protective effects of diallyl disulfide on carbon tetrachloride-induced hepatic oxidative damage and inflammatory response in rats.
Lee IC; Kim SH; Baek HS; Moon C; Kang SS; Kim SH; Kim YB; Shin IS; Kim JC
Food Chem Toxicol; 2014 Jan; 63():174-85. PubMed ID: 24246655
[TBL] [Abstract][Full Text] [Related]
8. [Arbutin ameliorates liver fibrosis in mice by inhibiting macrophage recruitment and regulating the Akt/NF-κB and Smad signaling pathways].
Cao J; Sun Y; Ding X; Li S; Chen B; Lan T
Nan Fang Yi Ke Da Xue Xue Bao; 2024 Apr; 44(4):652-659. PubMed ID: 38708497
[TBL] [Abstract][Full Text] [Related]
9. Ginkgo biloba extract mitigates liver fibrosis and apoptosis by regulating p38 MAPK, NF-κB/IκBα, and Bcl-2/Bax signaling.
Wang Y; Wang R; Wang Y; Peng R; Wu Y; Yuan Y
Drug Des Devel Ther; 2015; 9():6303-17. PubMed ID: 26664050
[TBL] [Abstract][Full Text] [Related]
10. Asiatic acid ameliorates CCl
Fan J; Chen Q; Wei L; Zhou X; Wang R; Zhang H
Drug Des Devel Ther; 2018; 12():3595-3605. PubMed ID: 30464391
[TBL] [Abstract][Full Text] [Related]
11. Cannabidiol attenuates cardiac dysfunction, oxidative stress, fibrosis, and inflammatory and cell death signaling pathways in diabetic cardiomyopathy.
Rajesh M; Mukhopadhyay P; Bátkai S; Patel V; Saito K; Matsumoto S; Kashiwaya Y; Horváth B; Mukhopadhyay B; Becker L; Haskó G; Liaudet L; Wink DA; Veves A; Mechoulam R; Pacher P
J Am Coll Cardiol; 2010 Dec; 56(25):2115-25. PubMed ID: 21144973
[TBL] [Abstract][Full Text] [Related]
12. Cannabidiol protects livers against nonalcoholic steatohepatitis induced by high-fat high cholesterol diet via regulating NF-κB and NLRP3 inflammasome pathway.
Huang Y; Wan T; Pang N; Zhou Y; Jiang X; Li B; Gu Y; Huang Y; Ye X; Lian H; Zhang Z; Yang L
J Cell Physiol; 2019 Nov; 234(11):21224-21234. PubMed ID: 31032942
[TBL] [Abstract][Full Text] [Related]
13. Selective inactivation of NF-kappaB in the liver using NF-kappaB decoy suppresses CCl4-induced liver injury and fibrosis.
Son G; Iimuro Y; Seki E; Hirano T; Kaneda Y; Fujimoto J
Am J Physiol Gastrointest Liver Physiol; 2007 Sep; 293(3):G631-9. PubMed ID: 17640975
[TBL] [Abstract][Full Text] [Related]
14. Oligo-peptide I-C-F-6 inhibits hepatic stellate cell activation and ameliorates CCl
Sun H; Chen G; Wen B; Sun J; An H; Pang J; Xu W; Yang X; He S
J Pharmacol Sci; 2018 Mar; 136(3):133-141. PubMed ID: 29501581
[TBL] [Abstract][Full Text] [Related]
15. PPARγ/NF-κB and TGF-β1/Smad pathway are involved in the anti-fibrotic effects of levo-tetrahydropalmatine on liver fibrosis.
Yu Q; Cheng P; Wu J; Guo C
J Cell Mol Med; 2021 Feb; 25(3):1645-1660. PubMed ID: 33438347
[TBL] [Abstract][Full Text] [Related]
16. Pien-Tze-Huang ameliorates hepatic fibrosis via suppressing NF-κB pathway and promoting HSC apoptosis.
Zheng H; Wang X; Zhang Y; Chen L; Hua L; Xu W
J Ethnopharmacol; 2019 Nov; 244():111856. PubMed ID: 30959141
[TBL] [Abstract][Full Text] [Related]
17. Alpinetin exerts anti-inflammatory, anti-oxidative and anti-angiogenic effects through activating the Nrf2 pathway and inhibiting NLRP3 pathway in carbon tetrachloride-induced liver fibrosis.
Zhu Z; Hu R; Li J; Xing X; Chen J; Zhou Q; Sun J
Int Immunopharmacol; 2021 Jul; 96():107660. PubMed ID: 33862553
[TBL] [Abstract][Full Text] [Related]
18. Tianhuang formula ameliorates liver fibrosis by inhibiting CCL2-CCR2 axis and MAPK/NF-κB signaling pathway.
Lan T; Chen B; Hu X; Cao J; Chen S; Ding X; Li S; Fu Y; Liu H; Luo D; Rong X; Guo J
J Ethnopharmacol; 2024 Mar; 321():117516. PubMed ID: 38042390
[TBL] [Abstract][Full Text] [Related]
19. Quercetin attenuates the activation of hepatic stellate cells and liver fibrosis in mice through modulation of HMGB1-TLR2/4-NF-κB signaling pathways.
Li X; Jin Q; Yao Q; Xu B; Li Z; Tu C
Toxicol Lett; 2016 Nov; 261():1-12. PubMed ID: 27601294
[TBL] [Abstract][Full Text] [Related]
20. Xia-yu-xue decoction (XYXD) reduces carbon tetrachloride (CCl4)-induced liver fibrosis through inhibition hepatic stellate cell activation by targeting NF-κB and TGF-β1 signaling pathways.
Liu C; Yuan X; Tao L; Cheng Z; Dai X; Sheng X; Xue D
BMC Complement Altern Med; 2015 Jun; 15():201. PubMed ID: 26122378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
